The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Defects in the interferon‐γ and interleukin‐12 pathways
Abstract
Summary: The interferon‐γ (IFN‐γ)/interleukin‐12 (IL‐12) pathway is a pivotal player in the immune system and is central to controlling mycobacterial infections. We highlight the most recent and relevant advances in understanding this pathway and their repercussions on basic and clinical science. Human mutations in IFN‐γ receptor‐1 (IFN‐γR1), IFN‐γR2, IL‐12p40, IL‐12 receptor‐β1, signal transducer and activator of transcription‐1, and nuclear factor‐κB essential modulator are analyzed in the context of genetic susceptibility to mycobacterial diseases. A diagnostic and therapeutic approach is described. The IFN‐γ/IL‐12 pathway is central in immune control of both environmental and autochthonous challenges, as reflected in human mutations and animal models. Besides being crucial for mycobacterial control, the IFN‐γ/IL‐12 pathway is also involved in the pathogenesis of autoimmune disease as well as tumor development and control. Genotype–phenotype correlations have been established for certain genes in this pathway, some of which have therapeutic implications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
Dighe, A. S., Richards, E., Old, L. J., & Schreiber, R. D. (1994) · Immunity · doi:10.1016/1074-7613(94)90087-6 · Cited by 663
Imada, K., & Leonard, W. J. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(00)00018-3 · Cited by 610 · cited 2×
“The Jak/Stat pathway is one of the most extensive signaling pathways downstream of the cytokine receptors (48, 49).”
BackgroundDorman, S. E., & Holland, S. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2901 · Cited by 429
Self-citationWSX-1 is required for the initiation of Th1 responses and resistance to L. major infection
Yoshida, H., Hamano, S., Senaldi, G., Covey, T., Faggioni, R., Mu, S., Xia, M., Wakeham, A. C., Nishina, H., Potter, J., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00206-0 · Cited by 406
Cited by
Regulation of Interferon‐γ During Innate and Adaptive Immune Responses
(2007) · Advances in Immunology · doi:10.1016/s0065-2776(07)96002-2 · Cited by 1,655
Bustamante, J., Boisson-Dupuis, S., Abel, L., & Casanova, J.-L. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.09.008 · Cited by 684
Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
Ghoreschi, K., Jesson, M. I., Li, X., Lee, J. L., Ghosh, S., Alsup, J. W., Warner, J. D., Tanaka, M., Steward-Tharp, S. M., Gadina, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003668 · Cited by 645
Hsu, A. P., Sampaio, E. P., Khan, J., Calvo, K. R., Lemieux, J. E., Patel, S. Y., Frucht, D. M., Vinh, D. C., Auth, R. D., Freeman, A. F., et al. (2011) · Blood · doi:10.1182/blood-2011-05-356352 · Cited by 638
Self-citationBrown-Elliott, B. A., Nash, K. A., & Wallace, R. J. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05030-11 · Cited by 541
Metadata
- Authors
- Rosenzweig, S. D., & Holland, S. M.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2005-01-17
- Volume
- 203
- Issue
- 1
- Pages
- 38-47
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W1979636314
- Cited by
- 219
- References
- 6
- FWCI
- 0.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Defects in the interferon‐γ and interleukin‐12 pathways. https://app.cochat.ai/papers/10.1111/j.0105-2896.2005.00227.x
- The paper
- Rosenzweig, S. D., & Holland, S. M. (2005). Defects in the interferon‐γ and interleukin‐12 pathways. Immunological Reviews. https://doi.org/10.1111/j.0105-2896.2005.00227.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.